INDV
Indivior Pharmaceuticals, Inc.
35.70$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +19.4% | +7.1% | +6.8% | -7.3% | +19.7% | -2.9% | -0.8% | -25.3% | -8.7% | |
| – | +23.7% | +8.5% | +2.3% | -12.7% | +21.7% | -12.3% | +0.0% | -33.7% | -22.3% | |
| – | +24.7% | +7.1% | +14.7% | -19.1% | +28.4% | -29.4% | -59.4% | +0.9% | -38.9% | |
| – | +24.7% | +7.1% | +14.7% | -19.1% | +28.4% | -18.5% | -54.3% | -22.0% | -39.1% | |
| – | +25.4% | +8.2% | -26.6% | +7.4% | -7.8% | +8.9% | +15.5% | +0.0% | +0.4% | |
| – | +26.8% | +50.0% | -6.4% | +27.4% | +2.2% | +20.6% | +17.8% | +31.9% | -14.0% | |
| – | – | – | – | -3.7% | -7.8% | -10.5% | – | – | – | |
| – | – | – | – | – | – | – | – | -60.0% | +0.0% | |
| – | – | – | – | -13.9% | +32.3% | -14.6% | -81.4% | -61.5% | -60.0% | |
| – | +9.5% | -10.1% | -2.6% | +0.4% | +12.4% | +6.0% | +13.2% | -14.8% | -21.9% | |
| – | -17.1% | -4.2% | -9.3% | -19.3% | +34.2% | +27.4% | +25.9% | -27.2% | -2.7% | |
| – | -95.0% | -20.0% | +125.0% | +33.3% | -8.3% | +0.0% | +9.1% | +133.3% | +39.3% | |
| – | +21.2% | +17.5% | +961.7% | -16.6% | -93.8% | +26.9% | +18.2% | +61.5% | -23.8% | |
| – | – | – | – | -1.3% | +3.9% | -0.8% | -0.4% | +33.5% | -7.9% | |
| – | – | – | +216.7% | -60.8% | +147.6% | -74.7% | -472.5% | – | – | |
| – | +8.6% | +27.4% | +10.2% | -9.5% | +9.7% | -8.9% | -122.5% | – | – | |
| – | +0.7% | +0.4% | +0.6% | -3.0% | +5.2% | -9.9% | +2.0% | -6.2% | -3.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.